Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents.

Citation
Salado, I. G., Zaldivar-Diez, J., Sebastián-Pérez, V., Li, L., Geiger, L., González, S., Campillo, N. E., Gil, C., Morales, A. V., Perez, D. I., & Martinez, A. (2017). Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents. European Journal of Medicinal Chemistry, 138, 328–342. https://doi.org/10.1016/j.ejmech.2017.06.060
DOI:
DOI: 10.1016/j.ejmech.2017.06.060
Year of publication:
2017